Suppression of tumor-derived Semaphorin 7A and genetic ablation of host-derived Semaphorin 7A impairs tumor progression in a murine model of advanced breast carcinoma
Open Access
- 3 October 2017
- journal article
- Published by Spandidos Publications in International Journal of Oncology
- Vol. 51 (5) , 1395-1404
Abstract
Solid tumors can generate a plethora of neurogenesis-related molecules that enhance their growth and metastasis. Among them, we have identified axonal guidance molecule Semaphorin 7A (SEMA7A) in breast cancer. The goal of this study was to determine the therapeutic effect of suppressing SEMA7A levels in the 4T1 murine model of advanced breast carcinoma. We used anti-SEMA7A short hairpin RNA (shRNA) to gene silence SEMA7A in 4T1 mammary tumor cells. When implanted into the mammary fat pads of syngeneic mice, SEMA7A shRNA-expressing 4T1 tumors exhibited decreased growth rates, deferred metastasis and reduced mortality. In vitro, SEMA7A shRNA-expressing 4T1 cells had weakened proliferative, migratory and invasive abilities, and decreased levels of mesenchymal factors. Atomic force microscopy studies showed that SEMA7A shRNA-expressing 4T1 cells had an increase in cell stiffness that corresponded with their decreased malignant potential. Genetic ablation of host-derived SEMA7A further enhanced the antitumor effects of SEMA7A shRNA gene silencing in 4T1 cells. Our preclinical findings demonstrate a critical role for SEMA7A in mediating mammary tumor progression.Keywords
This publication has 42 references indexed in Scilit:
- Differential marker expression by cultures rich in mesenchymal stem cellsBMC Cell Biology, 2013
- Semaphorin 7A Contributes to TGF-β–Mediated Liver FibrogenesisThe American Journal of Pathology, 2013
- Semaphorin7A and its receptors: Pleiotropic regulators of immune cell function, bone homeostasis, and neural developmentSeminars in Cell & Developmental Biology, 2013
- Semaphorin-7a reverses the ERF-induced inhibition of EMT in Ras-dependent mouse mammary epithelial cellsMolecular Biology of the Cell, 2012
- Secretome Signature of Invasive Glioblastoma MultiformeJournal of Proteome Research, 2011
- Deciphering the human platelet sheddomeBlood, 2011
- Structural Basis of Semaphorin-Plexin Recognition and Viral Mimicry from Sema7A and A39R Complexes with PlexinC1Cell, 2010
- Imagable 4T1 model for the study of late stage breast cancerBMC Cancer, 2008
- Semaphorin 7A plays a critical role in TGF-β1–induced pulmonary fibrosisJournal of Experimental Medicine, 2007
- Speed congenics: a classic technique in the fast lane (relatively speaking)Immunology Today, 1997